Drug Res (Stuttg) 2013; 63(S 01): S7
DOI: 10.1055/s-0033-1346707
Symposium der Paul-Martini-Stiftung
Georg Thieme Verlag KG Stuttgart · New York

Neuroprotective approaches in the animal model

M. Kerschensteiner
Institute of Clinical Neuroimmunology, Ludwig-Maximilians University Munich, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
15 November 2013 (online)

Our aim is to use modern in vivo microscopy techniques to reveal the cellular, subcellular and molecular mechanisms that mediate neuroinflammatory tissue damage in vivo. This approach can be illustrated using our recent insights into the in vivo pathogenesis of immune-mediated axon damage as an example. Immune-mediated axon damage plays a crucial role in inflammatory diseases of the central nervous system (CNS) like multiple sclerosis (MS) [1], as we know by now that the number of axons damaged by immune cells critically determines the clinical disability of MS patients. However we still understand very little about the process that leads to axon damage. Recently, we have used a spinal in vivo imaging approach [2], [3] to investigate the pathogenesis of immune-mediated axon damage in an animal model of multiple sclerosis. By time-lapse imaging of fluorescently labeled axons we could follow the slow and spatially restricted degeneration of axons in inflammatory CNS lesions. This “focal axonal degeneration” appears to be a novel type of axonal degeneration that is characterized by intermediate stages that can persist for several days and progress either to the degeneration or full recovery of the affected axons [4].

  • References

  • 1 Nave KA, Trapp BD. Multiple sclerosis: an immune or neurodegenerative disorder?. Ann Rev Neurosci 2008; 31: 247-269
  • 2 Misgeld T, Kerschensteiner M. In vivo imaging of the diseased nervous system. Nat Rev Neurosci 2006; 7: 449-463
  • 3 Kerschensteiner M, Schwab M, Lichtman JW, Misgeld T. In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat Med 2005; 11: 572-577
  • 4 Nikić I, Merkler D, Sorbara C, Brinkoetter M, Kreutzfeldt M, Bareyre FM, Brück W, Bishop D, Misgeld T, Kerschensteiner M. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 2011; 17: 495-499